Table of Contents.
I. 2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention Nov 1-2, 2022
II. Job Opening for Health Scientist Administrator (HSA) specializing in Safety Pharmacology and Toxicology at NIDA
III. NIDA is Recruiting Health Scientist Administrator (Program Officer), GS-12/13/14 in the Chemistry Pharmacology Physiology Branch in the Division of Neuroscience and Behavior (DNB).
IV. Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed) RFA-HD-23-003
V. Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
VI. NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed)
VII. BRAIN Initiative Brain Behavioral Quantification and Synchronization funding opportunity
I. 2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention Nov 1-2, 2022
Please mark your calendars for the annual 2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention. The Mini-Convention will be held as a 2-day virtual meeting on November 1-2, 2022. The annual NIDA-NIAAA Mini-Convention provides a forum for the Jacob P. Waletzky Award Lecture and presentations of current topics in neuroscience and addiction research.
The Mini-Convention also showcases research by premier early stage and junior investigators working in the fields of alcohol and substance abuse and addiction research through the Early Career Investigator Showcase (ECIS) symposium.
Three Mini-Symposia will be presented:
- Defining mechanisms that link sleep with Substance and Alcohol Use Disorders
- Reprogramming Glia for Brain Recovery: A Potential Future SUD Therapy
- Understanding human neurodevelopment amid a broader social context
The virtual event is FREE and open to the public, registration is required.
Additional information and links to the conference website can be found here.
II. Job Opening for Health Scientist Administrator (HSA) specializing in Safety Pharmacology and Toxicology at NIDA
National Institute on Drug (NIDA), US National Institutes of Health. The Division of Therapeutics and Medical Consequences in NIDA is seeking a Health Scientist Administrator (HSA) specializing in Safety Pharmacology and Toxicology. The HSA would be responsible for planning and implementing our comprehensive IND-enabling Toxicology Program for potential medications to treat substance use disorders as a Contracting Officer Representative (COR) on various contracts. The Toxicology Program supports standard Good Laboratory Practices (GLP) preclinical safety studies and specialized drug-drug interaction studies required for IND and NDA filings with the FDA in which the safety of potential medications alone and in the presence of drugs of abuse are established. The HSA would also serve as Program Official and/or Project Scientist on related grants and cooperative agreements assigned to the Division and would participate in multidisciplinary drug development teams. United States citizenship is required.
To inquire about applying to this job vacancy, please contact Nathan M. Appel, Ph.D. (nappel@nih.gov), Acting Chief, Medications Discovery and Toxicology Branch, Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, National Institutes of Health.
Below are the announcement links to the Health Scientist Administrator positions. Please be advised that the announcements can only be viewed at this time and the links will not be active until the announcements open on Wednesday, September 21, 2022 at 12:01am.
Delegated Examining (Open to the Public)
GS-12/13/14 Health Scientist Administrator (Program Officer/Scientist Review Officer)
Merit Promotion (Open to Status Candidates)
III. NIDA is Recruiting Health Scientist Administrator (Program Officer), GS-12/13/14 in the Chemistry Pharmacology Physiology Branch in the Division of Neuroscience and Behavior (DNB).
The National Institute on Drug Abuse (NIDA) is seeking an exceptional and motivated candidate for the position of Program Officer in the Chemistry Pharmacology Physiology Branch in the Division of Neuroscience and Behavior (DNB).
DNB supports basic and clinical neuroscience and behavioral research to address the public health problem of drug use and addiction by supporting research programs that provides an understanding of the neurobiological and behavioral mechanisms of drugs of use and their consequences. The Chemistry Pharmacology Physiology Branch supports all research related to chemistry and pharmacology of drugs including structural dynamics of receptors, computer-assisted drug design, intracellular signaling mechanisms, natural product chemistry, early drug discovery of treatments for addiction, and innovative mechanisms of drug delivery. The Program Officer will be responsible for creating new research initiatives and developing and overseeing research grant portfolios that leverage emerging and innovative approaches in chemistry and pharmacology of drugs.
Applicants must possess a Ph.D. degree and have knowledge in chemistry and drug design. Knowledge in biophysical and computational approaches for drug discovery and in the neurobiology of substance use disorders is preferred as is experience in grant writing and review.
Please apply for the GS-12/13/14 HSA (Program Officer) announcement through USAjobs.gov, open between September 21 through September 30, 2022.
Delegated Examining (Open to the Public)
Merit Promotion (Open to Status Candidates)
For more information, please contact: Dr. Sam Ananthan at: sam.annthan@nih.gov
IV. Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed) RFA-HD-23-003
This Funding Opportunity Announcement invites applications to form Transporter Elucidation Centers (TECs) as part of a Transporter Elucidation Network (TEN). TECs funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will address key knowledge gaps in functional transport of nutrients and drugs to the developing fetus and infant through a focus on human placenta, lactating mammary gland, and developing gut. Such projects may necessitate deorphanization and characterization of understudied transporters and functional variants. TECs funded by the National Institute of Drug Abuse (NIDA) will address knowledge gaps in the role of transporters in the blood brain barrier that transport substances and treatment agents relevant to NIDA. TECs will work together to generate knowledge and resources that will be shared with the broader research community to advance our understanding of nutrient, drug, and dietary supplement constituent transport to the developing fetus and infant.
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-003.html
Letter of Intent due October 30, 2022 and applications are due November 30, 2022.
V. Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-056.html
Funding Opportunity Purpose
This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) opioid exposure. This FOA will also support mechanistic studies of persistent or delayed pathophysiological effects after acute exposure to UPS opioids.
Interested applicants are strongly encouraged to contact the Program Officer/s listed for related queries.
Additionally, please forward this funding opportunity to colleagues and/or collaborators who might be interested.
Best regards,
Kiran Vemuri, Ph.D.
Program Officer
Division of Neurosciences and Behavioral Research
Chemistry, Pharmacology and Physiology Branch
National Institute on Drug Abuse
National Institute of Health
P: 301.435.4446
VI. NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-037.html with a submission deadline of 11/29/22
On behalf of the NIH Blueprint for Neuroscience Research, NIDA seeks grant applications that will establish research training programs in computational neuroscience and behavior for undergraduate and predoctoral level students. The training program should expose undergraduate and graduate students to a wide range of neuroscience and behavioral questions, quantitative methods, and experimental systems to ensure a strong dual foundation in clinical and quantitative science.
Applications should establish research training programs in computational neuroscience and behavior for undergraduate and predoctoral level students. The training program should provide:
· A strong foundation in research design, methods, and analytic techniques appropriate for the conduct of computational research of neuroscience and behavior
· The enhancement of the trainees' ability to conceptualize and think through research problems with increasing independence
· The enhancement of the trainees' understanding of neuroscience and the relationship of their research training to health and disease
· Experience conducting research using state-of-the-art quantitative methods as well as presenting and publishing their research findings
· The opportunity to interact with members of the scientific community at appropriate scientific meetings and workshops, including across all funded programs in this announcement
· Optionally, applicants may propose to develop a short-course or summer course that could be open to scientists at any stage of the career continuum
A T90/R90 application must include both components (T90 and R90). Applicants will submit a single grant application and, if selected for funding, two separate awards will be issued: an NRSA T90 (Research Training award) and a non-NRSA R90 (Research Education award), which are based on distinct research training and education-related funding authorities. Each application:
· Must include a full-time undergraduate research training component that will combine coursework and hands-on laboratory research experience (R90)
· Must include a full-time Ruth L. Kirschstein National Research Service Award (NRSA) institutional predoctoral training component (T90)
· May include a full-time non-NRSA institutional predoctoral training component (R90)
· May include a short-term research education component (e.g., short course or workshop) that may include scientists at any stage of the career continuum as participants (R90)
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. NIH intends to fund an estimate of 4-5 awards, corresponding to a total of $2.2M, for fiscal year 2023. The maximum project period is five years.
Contacts:
- John Fedota, PhD (john.fedota@nih.gov)
- James Gnadt, Ph.D. (gnadtjw@mail.nih.gov)
----------------------
VII. BRAIN Initiative Brain Behavioral Quantification and Synchronization funding opportunity
Please join us on October 24, 1:30 pm EST for a pre-application information and technical assistance webinar on the new BRAIN Initiative funding opportunity announcement (FOA) Brain Behavior Quantification and Synchronization (BBQS) (RFA-MH-22-240). This funding opportunity seeks to support the development and validation of next-generation tools, methods, and analytic approaches to precisely quantify complex behaviors and combine them with simultaneous recordings of brain activity in humans. BRAIN Initiative staff, including program officers and scientific review officers, will make a brief presentation describing the FOA's research goals, areas of special interest, preapplication Information, and technical assistance. BRAIN staff will be available for a question and answer session following the presentation. Use this link to register by October 19, 2022, but note slots are going fast! Please reach out to BRAINBBQS@od.nih.gov or lizzy.ankudowich@nih.gov with any questions regarding this funding opportunity.
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
No comments:
Post a Comment